Ledger.Open graph →
SEC Form D · filed August 31, 2020

NX Pharmagen Inc

Offering
$1.0M
Sold
$486K
Exemption
Rule 506(b)
Industry
Other Health Care
Location
LOUISVILLE, KY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Brian Brohman · Louisville, KYExec · DirectorAlan M. Ezrin · Louisville, KYDirectorRobert Saunders · Louisville, KYDirectorFred Mermelstein · Lexington, KYDirectorJill A. Vogel · Troy, MIExec · DirectorMatthew George · Boston, MADirectorJeffery A. Sugg · Troy, MIDirectorHayden Watson · Bend, ORDirectorMark C. Griege · DALLAS, TXDirectorJohn B. Robertshaw · NEW YORK, NYDirectorTom B. Fortin · NEW YORK, NYDirectorTodd B. Myers · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗